35 results on '"Cahn, Pedro"'
Search Results
2. Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial
3. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials
4. Fostemsavir
5. Candidates for inclusion in a universal antiretroviral regimen
6. Efficacy and Safety of Tipranavir Coadministered with Ritonavir in HIV-1-Infected Children and Adolescents
7. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria
8. Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients
9. Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children
10. Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
11. Cancer in HIV-Infected Persons From the Caribbean, Central and South America
12. The Coughing Patient: TB or Not TB; That Is The Question
13. Hepatitis B Virus, Hepatitis C Virus and HIV Coinfection Among People Living With HIV/AIDS in Buenos Aires, Argentina
14. Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents
15. Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean
16. A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients
17. Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults
18. Uncommon Hepatitis B Virus and/or Hepatitis C Virus Occult Infection in HIV-Positive Patients With Abnormal Level of Hepatic Enzyme
19. Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents
20. The role of HIV research in building health system capacity in developing countries
21. The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART
22. Management of Human Immunodeficiency Virus–Infected Pregnant Women at Latin American and Caribbean Sites
23. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth
24. Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients
25. Safe Treatment Interruptions in Patients With Nadir CD4 Counts of More Than 350 Cells/μL
26. Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults
27. Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir
28. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects
29. Randomized, Controlled Study of the Effects of a Short Course of Prednisone on the Incidence of Rash Associated With Nevirapine in Patients Infected With HIV-1
30. Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
31. Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children
32. Higher Rate of Toxicity With No Increased Efficacy When Hydroxyurea Is Added to a Regimen of Stavudine Plus Didanosine and Nevirapine in Primary HIV Infection
33. Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals
34. Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine
35. No Evidence of HIV-2 Infection in Argentina
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.